SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145 | -99.8% | 7 | -99.6% | 0.00% | -100.0% |
| Q2 2023 | $81,721 | +12.1% | 1,738 | 0.0% | 0.06% | +6.8% |
| Q1 2023 | $72,927 | +10.0% | 1,738 | 0.0% | 0.06% | +3.5% |
| Q4 2022 | $66,287 | -2.5% | 1,738 | 0.0% | 0.06% | +3.6% |
| Q3 2022 | $68,000 | +21.4% | 1,738 | 0.0% | 0.06% | +34.1% |
| Q2 2022 | $56,000 | -6.7% | 1,738 | -3.9% | 0.04% | +2.5% |
| Q1 2022 | $60,000 | -24.1% | 1,809 | -2.2% | 0.04% | -21.6% |
| Q4 2021 | $79,000 | -9.2% | 1,849 | -6.0% | 0.05% | -16.4% |
| Q3 2021 | $87,000 | -22.3% | 1,966 | 0.0% | 0.06% | -23.8% |
| Q2 2021 | $112,000 | -23.8% | 1,966 | 0.0% | 0.08% | -30.4% |
| Q1 2021 | $147,000 | -12.0% | 1,966 | +1.9% | 0.12% | -18.4% |
| Q4 2020 | $167,000 | – | 1,930 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |